Notably, the main EMT-associated genes dysregulated upon upregulation of PBX3 in HCC were different from those dysregulated in colorectal cancer and in gastric cancer upon upregulation of PBX3, indicating that PBX3 could activate a novel EMT-related pathway in HCC. This evidence concerns the gene PBX3 and gastric cancer.